The Efficacy and Safety of Alprazolam Versus Other Benzodiazepines in the Treatment of Panic Disorder
Open accessThe DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
We performed a meta-analysis of all single- or double-blind, randomized controlled trials comparing alprazolam to another benzodiazepine in the treatment of adult patients meeting the Diagnostic and Statistical Manual of Mental Disorders, Third or Fourth Edition, criteria for panic disorder or agoraphobia with panic attacks. Eight studies met inclusion criteria, describing a total of at least 631 randomized patients. In the pooled results, there were no significant differences in efficacy between alprazolam and the comparator benzodiazepines on any of the prespecified outcomes: improvement in mean panic attack frequency (between-arm weighted mean difference of 0.6 panic attacks per week; 95% confidence interval [CI], -0.3 to 1.6), improvement in Hamilton Anxiety Rating Scale score (weighted mean difference of 0.8 points; 95% CI, -0.5 to 2.1), and proportion of patients free of panic attacks at the final evaluation (pooled relative risk, 1.1; 95% CI, 0.9-1.4). Statistical heterogeneity on prespecified outcomes was not eliminated by stratification on baseline anxiety level. The available evidence fails to demonstrate alprazolam as superior to other benzodiazepines for the treatment of panic disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a 2011 meta-analysis of all single or double-blind, randomized controlled trials comparing alprazolam with other benzodiazepines in the treatment of panic disorder found no significant differences on any of the outcomes of clinical efficacy, including mean panic attack frequency, improvement in HAM-A score, and proportion of patients free of panic attacks at the final evaluation (Moylan et al., 2”
From A Review of Alprazolam Use, Misuse, and Withdrawal (2018) · cites this paper as Moylan et al., 2011
Citations
Cites
Multicenter Collaborative Panic Disorder Severity Scale
Shear, M. K., Brown, T. A., Barlow, D. H., Money, R., Sholomskas, D. E., Woods, S. W., Gorman, J. M., & Papp, L. A. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.11.1571 · Cited by 1,001
A random‐effects regression model for meta‐analysis
Berkey, C. S., Hoaglin, D. C., Mosteller, F., & Colditz, G. A. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140406 · Cited by 879
Ballenger, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290027004 · Cited by 564
Benzodiazepine use, abuse, and dependence.
O’Brien, C. P. (2005) · PubMed · Cited by 539
(2004) · PubMed · Cited by 296
Klerman, G. L. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.160.2.191 · Cited by 229
Pecknold, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290043006 · Cited by 204
Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia
Furukawa, T. A., Watanabe, N., & Churchill, R. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004364.pub2 · Cited by 195
Diazepam and Propranolol in Panic Disorder and Agoraphobia
Noyes, R. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790140077009 · Cited by 184
Pivotal studies of clonazepam in panic disorder.
Davidson, J. R. T., & Moroz, G. (1998) · PubMed · Cited by 178
Discontinuation of alprazolam treatment in panic patients
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.3.303 · Cited by 172
Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
Charney, D. S., Woods, S. W., Goodman, W. K., Rifkin, B. G., Kinch, M., Aiken, B. E., Quadrino, L. M., & Heninger, G. R. (1986) · PubMed · Cited by 155
Pollack, M. H., Simon, N. M., Worthington, J. J., Doyle, A. L., Peters, P., Toshkov, F., & Otto, M. W. (2003) · Journal of Psychopharmacology · doi:10.1177/02698811030173009 · Cited by 124 · cited 2×
“The advantage of combining therapies remains unclear.47,48 A few studies have compared the utility of high-potency benzodiazepines, primarily clonazepam, as adjunctive therapy to SSRIs.49,50 These studies suggest possible short-term advantages to coadministration, but this effect is not sustained beyond a few weeks of…”
BackgroundDünner, D. L., Ishiki, D., Avery, D., Wilson, L. G., & Hyde, T. S. (1986) · PubMed · Cited by 120
Alprazolam is relatively more toxic than other benzodiazepines in overdose
Isbister, G. K., O'Regan, L., Sibbritt, D., & Whyte, I. M. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02089.x · Cited by 116 · cited 1×
“Alprazolam is increasingly being used as a drug of abuse(26) and is more toxic than other benzodiazepines in overdose.(27) Despite this, alprazolam prescribing remains common and continues to rise.”
BackgroundNoyes, R. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290037005 · Cited by 116
Controlled discontinuation of benzodiazepine treatment for patients with panic disorder
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.4.517 · Cited by 111
Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
Tesar, G. E., Rosenbaum, J. F., Pollack, M. H., Otto, M. W., Sachs, G. S., Herman, J. B., Cohen, L. S., & Spier, S. A. (1991) · PubMed · Cited by 109
Cognitive behavior therapy for treatment-refractory panic disorder.
Pollack, M. H., Otto, M. W., Kaspi, S. P., Hammerness, P. G., & Rosenbaum, J. F. (1994) · PubMed · Cited by 108
Overview of the Cross-National Collaborative Panic Study: I. Efficacy in Short-term Treatment
Klerman, G. L. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290021003 · Cited by 104
Diazepam versus alprazolam for the treatment of panic disorder.
Noyes, R., Burrows, G. D., Reich, J. H., Judd, F. K., Garvey, M. J., Norman, T. R., Cook, B. L., & Marriott, P. F. (1996) · PubMed · Cited by 97
Anxiolytic, hypnotic and sedative medication use in Australia
Hollingworth, S. A., & Siskind, D. J. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1899 · Cited by 92
Royal Australian and New Zealand College Of Psychiatrists Clinical Practice Guidelines Team For Panic Disorder And Agoraphobia (2003) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2003.01254.x · Cited by 80
Dementia and antipsychotic drugs.
Raskind, M. A., Risse, S. C., & Lampe, T. H. (1987) · PubMed · Cited by 79
Panic Disorder: Long-Term Pharmacotherapy and Discontinuation
Rickels, K., & Schweizer, E. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199812001-00004 · Cited by 77
Long-term Outcome After Acute Treatment with: Alprazolam or Clonazepam for Panic Disorder
POLLACK, M. H., OTTO, M. W., TESAR, G. E., COHEN, L. S., MELTZER-BRODY, S., & ROSENBAUM, J. F. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199308000-00005 · Cited by 77
Cox, B. J., Endler, N. S., Lee, P. S., & Swinson, R. P. (1992) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/0005-7916(92)90034-g · Cited by 71
Moroz, G., & Rosenbaum, J. F. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0907 · Cited by 68
The Alprazolam to Clonazepam Switch for the Treatment of Panic Disorder
HERMAN, J. B., ROSENBAUM, J. F., & BROTMAN, A. W. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198706000-00012 · Cited by 63 · cited 1×
“For these reasons, clonazepam, a high-potency benzodiazepine with longer halflife,(58) has received attention as an alternative to alprazolam, particularly in patients experiencing interdose anxiety.(59) A few studies have demonstrated successful discontinuation of clonazepam,(54,60) with decreased withdrawal symptoms…”
BackgroundBenzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
Charney, D. S., & Woods, S. W. (1989) · PubMed · Cited by 62
Crevoisier, C., Delisle, M. C., Joseph, I., & Foletti, G. (2003) · European Neurology · doi:10.1159/000069089 · Cited by 62 · cited 1×
“A few studies have demonstrated successful discontinuation of clonazepam,(54,60) with decreased withdrawal symptoms attributed to its prolonged elimination half-life.(58) As previously mentioned, alprazolam prescription rates are increasing despite no longer being a recommended firstline treatment strategy for PD.”
BackgroundThe use of the Panic and Agoraphobia Scale in a clinical trial
Bandelow, B., Brunner, E., Broocks, A., Beinroth, D., Hajak, G., Pralle, L., & Rüther, E. (1998) · Psychiatry Research · doi:10.1016/s0165-1781(97)00118-2 · Cited by 62
Long-Term Follow-up after a Drug Trial for Panic Disorder
Katschnig, H., Amering, M., Stolk, J. M., Klerman, G. L., Ballenger, J. C., Briggs, A., Buller, R., Cassano, G., Garvey, M., Roth, S. M., et al. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.167.4.487 · Cited by 60
Lorazepam Vs. Alprazolam in the Treatment of Panic Disorder
Schweizer, E., Pohl, R., Balon, R., Fox, I., Rickels, K., & Yeragani, V. (1990) · Pharmacopsychiatry · doi:10.1055/s-2007-1014489 · Cited by 58 · cited 1×
“Only 4 studies clearly described performing an ITT analysis for all outcomes.(36,38,40,42) Begg test suggested that small study effects were present, raising the possibility of publication bias.”
BackgroundPhysical dependence on benzodiazepines: differences within the class
Wolf, B., & Griffiths, R. R. (1991) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(91)90044-y · Cited by 49
Benzodiazepines in panic disorder and agoraphobia
Sheehan, D. V. (1987) · Journal of Affective Disorders · doi:10.1016/0165-0327(87)90021-8 · Cited by 48
A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
Rizley, R. C., Rj, K., McNair, D. M., & Frankenthaler, L. M. (1986) · PubMed · Cited by 48
Andrews, G., Corry, J., Browne, M. A. O., & Shepherd, L. (2003) · Australian & New Zealand Journal of Psychiatry · Cited by 48
PECKNOLD, J., LUTHE, L., MUNJACK, D., & ALEXANDER, P. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199410000-00005 · Cited by 46 · cited 1×
“Only 4 studies clearly described performing an ITT analysis for all outcomes.(36,38,40,42) Begg test suggested that small study effects were present, raising the possibility of publication bias.”
BackgroundSimon, N. M., Otto, M. W., Worthington, J. J., Hoge, E. A., Thompson, E. H., LeBeau, R. T., Moshier, S. J., Zalta, A. K., & Pollack, M. H. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04485blu · Cited by 45
A 15-year follow-up study of patients with panic disorder
Andersch, S., & Hetta, J. (2003) · European Psychiatry · doi:10.1016/j.eurpsy.2003.03.007 · Cited by 45
Tapering Clonazepam in Patients With Panic Disorder After at Least 3 Years of Treatment
Nardi, A. E., Freire, R. C., Valença, A. M., Amrein, R., de Cerqueira, A. C. R., Lopes, F. L., Nascimento, I., Mezzasalma, M. A., Veras, A. B., Sardinha, A., et al. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181dcb2f3 · Cited by 41
Tesar, G. E., Rosenbaum, J. F., Mh, P., Herman, J. B., Gs, S., Mahoney, E. M., Ls, C., McNamara, M., & Goldstein, S. (1987) · PubMed · Cited by 40
Discontinuation reactions to alprazolam in panic disorder
Pecknold, J. C. (1993) · Journal of Psychiatric Research · doi:10.1016/0022-3956(93)90025-w · Cited by 36
Psychotropic Drug Prescribing in the United States: Extent, Costs, and Expenditures
Greenblatt, D. J., Harmatz, J. S., & Shader, R. I. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318209cf05 · Cited by 36
Assessing the efficacy of treatments for panic disorder and agoraphobia. I. Methodological problems
Bandelow, B., Hajak, G., Holzrichter, S., Kunert, H. J., & Rüther, E. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199506000-00004 · Cited by 35
Buykx, P., LOXLEY, W. M., Dietze, P., & Ritter, A. J. (2010) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1753-6405.2010.00573.x · Cited by 31
Improvement of Quality of Life in Panic Disorder with Escitalopram, Citalopram, or Placebo
Bandelow, B., Stein, D., Dolberg, O., Andersen, H., & Baldwin, D. (2007) · Pharmacopsychiatry · doi:10.1055/s-2007-984398 · Cited by 31 · cited 1×
“The use of broad measures may not provide reliable evidence of an overall treatment effect, specifically in domains not associated with panic attacks (eg, quality of life).(45) A further limitation of this data set is the absence of systematic measures of the known adverse event profile of these agents, restricting ri…”
BackgroundSelf-citationChronic diazepam exposure decreases transcription of the rat GABAA receptor γ2-subunit gene
Holt, R. A., Martin, I. L., & Bateson, A. N. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00129-0 · Cited by 29
Double-Blind Comparison of Alprazolam and Adinazolam for Panic and Phobic Disorders
Pyke, R. E., & Greenberg, H. (1989) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198902000-00004 · Cited by 27
Lorazepam vs. alprazolam in the treatment of panic disorder.
Schweizer, E. E., Fox, I., Case, G. W., & Rickels, K. (1988) · PubMed · Cited by 21
Hooper, S. C., Bruno, R., Sharpe, M. R., & Tahmindjis, A. J. (2009) · Australasian Psychiatry · doi:10.1080/10398560902998626 · Cited by 12
Peters, R. J., Meshack, A., Kelder, S. H., Webb, P., Smith, D., & Garner, K. (2007) · Journal of Drug Education · doi:10.2190/de.37.4.e · Cited by 11
Alprazolam Abuse in Texas, 1998–2004
Forrester, M. B. (2005) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390500246811 · Cited by 11
Research works printed but not linked: 1
- Meco, 1989, Etizolam: a new therapeutics possibility in the treatment of panic disorder., Adv Ther, 6, 196
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“While it has been suggested that alprazolam may be more effective, a metaanalysis found no evidence that it was superior to other benzodiazepines for the treatment of panic disorder [252].”
BackgroundA Review of Alprazolam Use, Misuse, and Withdrawal
Ait-Daoud, N., Hamby, A. S., Sharma, S., & Blevins, D. (2018) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000350 · Cited by 195
“…other benzodiazepines in the treatment of panic disorder found no significant differences on any of the outcomes of clinical efficacy, including mean panic attack frequency, improvement in HAM-A score, and proportion of patients free of panic attacks at the final evaluation (Moylan et al., 2011).”
Benzodiazepines Remain Important Therapeutic Options in Psychiatric Practice
Dubovsky, S. L., & Marshall, D. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000524400 · Cited by 171
Serotonin in anxiety and panic: Contributions of the elevated T-maze
Zangrossi, H., & Graeff, F. G. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.03.007 · Cited by 167
Sahn, J. J., Granger, B. A., & Martin, S. F. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob00835a · Cited by 47
Metadata
- Authors
- Moylan, S., Staples, J., Ward, S. A., Rogerson, J., Stein, D. J., & Berk, M.
- Affiliations
- Mental Health Research Institute (AU)
- Western Health (AU)
- Government of Prince Edward Island (CA)
- University of Cape Town (ZA)
- Corresponding author
- Moylan, Steven
- Berk, Michael
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2011-10
- Volume
- 31
- Issue
- 5
- Pages
- 647-652
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W1972150366
- Cited by
- 34
- References
- 55
- Citations by year
- 2025: 4 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 2 · 2016: 4 · 2015: 3 · 2014: 6 · 2013: 2 · 2012: 2
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- Locations
- Journal of Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- alprazolam, benzodiazepines, panic disorder, treatment efficacy, drug safety, comparative drug effectiveness
- MeSH terms
- Agoraphobia, Alprazolam, Benzodiazepines, Humans, Psychiatric Status Rating Scales, Anti-Anxiety Agents, Randomized Controlled Trials as Topic, Panic Disorder, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.